Video & Transcript : 'clinical trial' :

Page 32 of 395
MO

Missouri 2026 Regular Session

Professional Registration and Licensing Mar 4th, 2026

Professional Registration and Licensing

Transcript Highlights:
  • the provision that you all have heard and passed out 20 to 0 that fixes the issue of doing your clinical
  • 2999 Regulatory refinement through the Board of Optometry and House Bill 2999 instead micromanages clinical
  • But when you take the RRT, it’s the multiple choice in addition to the clinical setting trials.
  • I don’t think it’s all that much harder if we’re just talking about a clinical setting test or trial.
  • Whereas the RRT, they're required to go and take what's called a clinical simulation exam, where they
Summary: The committee first took up House Bill 3111, which concerns bail bonds oversight. Representative Phelps offered a committee substitute that moved bail bondsmen into the existing Board of Private Investigators, Private Fire Investigators, and Professional Surety Bail Bonds to avoid a fiscal note. An amendment was adopted to remove fee caps in the substitute, and the committee then adopted the revised substitute and voted it do pass 21-0. The committee then heard Senate Substitute No. 2 for Senate Bill 1233, the CPA licensure bill, along with related provisions for social work supervisors and speech pathologists. Senator Trent and supporters from the Missouri Society of CPAs, the speech-language association, the social work community, and the State Auditor’s Office said the bill would address CPA shortages by creating a new licensure path based more on experience, while preserving exam standards and adding reciprocity. No opposition was offered, and the hearing concluded without a vote. House Bill 2999 on optometry scope of practice drew extensive testimony and debate. The sponsor and ophthalmology witnesses described the bill as a negotiated compromise that would codify specific procedures optometrists may perform, while opponents from optometry argued it would freeze scope in statute, limit modernization, and require repeated legislative action as standards change. Witnesses disagreed sharply over whether the bill improved patient safety and access, whether the procedures were already within current practice, and whether surgical procedures such as lasers should be included. The bill was heard but no committee action was taken in the transcript. Finally, the committee heard House Bill 2957 on respiratory therapist licensure. Representative Castile and respiratory care witnesses said the bill would phase out the CRT as the entry credential for new applicants in favor of the higher RRT standard, while grandfathering current CRTs and adding renewal audits to confirm active credentials. Supporters said the change reflects current training standards and would raise patient-care quality without reducing workforce numbers. No opposition testimony was presented, and the hearing adjourned without a vote.
NH

New Hampshire 2026 Regular Session

House Judiciary (02/25/2026)

Judiciary

Transcript Highlights:
  • I was um going was not a medical clinic.
  • And so into becoming a medical clinic.
  • ,</c> um in outside clinics, um in outside clinics, excuse<00:52:36.800><c> me.
  • </c> jury trial in capital cases. jury trial in capital cases.
  • </c><03:11:52.800><c> by</c> capital punishment without trial by capital punishment without trial by
Committee: House Judiciary
Keywords: 1189, house, all
CA
Transcript Highlights:
  • trials to see that they get the best care possible for them.
  • I think, one, today there's no categorization of what's clinical, what's non-clinical.
  • I think many of these processes are clinically adjacent.
  • We’re also dealing with primary care, clinics, CBOs.”
  • trials and quality improvement.
Summary: The joint informational hearing of the Assembly Health and Privacy Committees focused on generative AI in health care, with opening remarks emphasizing both its potential to improve care and its risks around privacy, bias, liability, workforce impacts, and unequal access. Chair Bauer-Kahan and Chair Bonta framed the discussion around how California can encourage beneficial innovation while protecting patients, especially given the sensitivity of health data and the possibility that AI could worsen existing disparities if not carefully governed. The first panel featured representatives from Cedars-Sinai, Kaiser Permanente, Penguin AI, and Google, who described current uses of AI such as ambient clinical scribes, nursing documentation tools, imaging triage, maternal-fetal risk prediction, and administrative automation. Speakers said these tools can reduce clinician burden, improve patient experience, speed treatment, and in some cases improve outcomes, including a reported mortality benefit from a Kaiser predictive model and faster thrombectomy times at Cedars-Sinai. Members raised concerns about accuracy with accents and multilingual visits, whether predictive tools could reinforce bias or lead to more interventions such as C-sections, and how to ensure a human remains in the loop for important decisions. The second panel, including representatives from the California Health Care Foundation, UC Berkeley, and Stanford, focused on policy and governance challenges. Testimony highlighted examples of AI supporting homelessness outreach and community health work, but also warned that biased algorithms can encode inequities, especially when trained on data that reflect under-treatment of Black, rural, or low-income patients. Witnesses urged clearer standards for trustworthy AI, stronger monitoring and governance structures, better data access for accountability, and attention to the safety net’s limited resources. Several speakers argued that states should require health systems to have AI governance processes, clarify liability between developers and deployers, and regulate downstream uses of AI while preserving access to data for lifesaving research and oversight.
WA

Washington 2025-2026 Regular Session

Senate Law & Justice Jan 13th, 2026

Transcript Highlights:
  • And this is another way to get people the speedy trial that they deserve. The standards are high.
  • just about getting the personnel to perform the tox analysis and being able to testify to that in trial
  • Which is minimize time to trial, increase accountability, and community safety. Thank you.
  • When testing is performed by an out-of-state laboratory or private clinic that refuses to participate
  • Our highly decentralized system for providing criminal public defense services across dozens of trial
Summary: The committee began with introductions and then heard Senate Bill 5865, which would repeal statutory garnishment answer forms and require use of Washington Pattern Forms Committee forms instead. Staff, the prime sponsor, and judges’ association witnesses said the bill is a technical fix that would make garnishment calculations more accurate and efficient without changing substantive law. A collectors’ association witness said the current statutory form can be used if needed until new forms are available and raised concerns about the timeliness of pattern form updates, but was open to working on language. The public hearing on SB 5865 was then closed. The committee next heard Senate Bill 5880, which would allow blood and breath toxicology results to be admissible if tested by an ISO/IEC 17025-certified or accredited forensic lab. The sponsor and supporters, including the Seattle city attorney and traffic safety experts, described severe backlogs at the state toxicology lab, with some DUI blood results taking many months or longer and cases expiring before charges can be filed. Counties, prosecutors, sheriffs, and defense representatives generally agreed the backlog is a serious problem, but several warned the bill could shift costs to local governments, create uneven access to private testing, and raise due process concerns unless discovery cooperation is required. The committee then closed the hearing on SB 5880. Senate Bill 5912 would reinstate the indigent defense task force to study Washington’s public defense system and report recommendations by 2028. Supporters from counties, cities, public defense offices, and tribal interests said the statewide shortage of defense attorneys and rising costs are straining local budgets and delaying access to counsel, especially in rural and eastern Washington. Some witnesses urged the bill be amended to add more stakeholder representation, including clients and practitioners, and cautioned that the task force should not delay immediate action on funding and caseload standards. The hearing on SB 5912 was then closed. The committee also heard Senate Bill 5837, a broad update to guardianship, conservatorship, and protective arrangement procedures. The bill would lower the minimum age for a proposed guardian from 21 to 18, expand notice options, clarify appointment of counsel, and streamline service and hearing procedures. Testimony was largely supportive, especially from kinship caregivers, legal aid, and estate-law practitioners who said the bill would reduce costly publication requirements and improve access to justice, though some witnesses requested amendments on notice, waiver language, emergency procedures, and counsel provisions. The committee reported 40 pro and 70 con sign-ins on the bill, then moved on. Finally, the committee began hearing Senate Bill 5855, which would prohibit law enforcement officers, including federal agents, from wearing facial coverings during public interactions except in limited circumstances such as undercover work, SWAT operations, or health and safety needs. The sponsor and supporters said the bill is intended to increase transparency, accountability, and trust, especially for immigrant and marginalized communities, while opponents argued it could endanger officers, conflict with federal authority, and is tied to ongoing litigation over similar California legislation. Testimony was sharply divided, with some witnesses emphasizing public fear and trauma from masked officers and others arguing the bill would make officers more vulnerable and create constitutional problems. The hearing continued with additional public testimony after the excerpt ended.
MO

Missouri 2026 Regular Session

Health and Mental Health Feb 19th, 2026

Health and Mental Health

Transcript Highlights:
  • He’s with Mizzou’s clinical research department.
  • We have interest in doing all those things, so looking forward to doing clinical trials for treatment
  • A lot of rural areas may have a clinic. There's mobile delivery services.
  • We work with Compass Health Clinic, and we are limited to just three of those clinics because we don't
  • The denial occurred despite the treating oncologist's clinical judgment, the patient-specific clinical
Summary: The committee first met in executive session and voted House Bill 2309, Representative Jones’ Oregon Harvesting bill, do pass by a vote of 13 ayes and no nays. The committee then moved to public testimony on House Bill 1881, which would schedule xylazine as a controlled substance. Representative Bill Allen said the bill is intended to address xylazine’s role in fentanyl-related overdoses, improve tracking and enforcement, and preserve legitimate veterinary use through carve-outs. A veterinarian from the University of Missouri testified in support, emphasizing xylazine’s long-standing and safe veterinary use and the need to protect agricultural practice while targeting illicit diversion. No opposition was presented, and testimony on the bill concluded. The committee then heard House Bill 1855, which would add alpha-gal syndrome to Missouri’s reportable conditions and create a reporting/surveillance framework. Sponsor Representative Matthew Overcast said the bill was revised to shift reporting from providers to private labs, create a standalone non-communicable disease reporting section, and support data collection for prevalence, education, and federal funding opportunities. Supporters included a lobbyist for the AlphaGal Alliance, a University of Missouri dermatologist/researcher, Extension staff, cattle industry representatives, and multiple patients and family members who described severe dietary restrictions, anxiety, school and work impacts, and the need for better public awareness and treatment research. Opponents argued the bill’s language would expand DHSS authority too broadly, especially the provision allowing the department to designate and enforce rules for noncommunicable diseases, and suggested narrowing the bill and adding opt-in protections. No vote was taken. Finally, the committee began hearing House Bill 2355, Representative Holly Jones’ “food as medicine” bill. Jones argued that nutrition should be treated as a public health intervention and described medically tailored meals, produce prescriptions, and nutrition counseling as tools that can improve outcomes and reduce costs. In questions, members raised concerns about how the proposal would interact with existing food assistance programs such as SNAP, WIC, school meals, and other federal nutrition benefits, and whether the bill would create a new entitlement or duplicate existing aid. The hearing on HB 2355 was still in progress when the transcript ended.
LA

Louisiana 2026 Regular Session

Health and Welfare Apr 15th, 2026

Health and Welfare

Transcript Highlights:
  • So no health care business, no medical clinic is now included in this bill? That's correct.
  • I promise they will not have an answer because the trials have never been done.
  • I promise they will not have an answer because the trials have never been done.
  • So none of the SARS-CoV-1 or two trials ever resulted in anything positive.
  • So if you were a physician, as I was, that went through the trials and saw also new people that were
TX

Texas 89th Regular

S/C on Disease Prevention & Women's & Children's Health Mar 27th, 2025

S/C on Disease Prevention & Women's & Children's Health

Transcript Highlights:
  • trials.
  • Trials, and avoidance of unnecessary tests.
  • For NEC, the clinical picture is very confounding initially. In the worst case, we see abdominal...
  • Basaldua, a clinical pharmacist and professor. ...and a published author on health literacy, and I strongly
  • I do see patients in the clinic. The first one is a 67-year-old man.
TX
Transcript Highlights:
  • There are safety edits and clinical edits.
  • My clinic did not close in 2020.
  • That put my clinic in a very big bind.
  • We exempted clinical trials, obviously, for people that have subjected themselves to clinical trials.
  • I've been reading the Cleveland Clinic study that just recently came out.
CA

California 2025-2026 Regular Session

Assembly Appropriations Committee Jun 24th, 2026

Appropriations

Transcript Highlights:
  • At UC Davis, I performed some of the first primary trials on the HIV drug tenofovir, which over the last
  • At UC Davis, I performed some of the first primary trials on the HIV drug tenofovir, which over the last
  • Our research, supported largely by federal funding, built the foundation for the human clinical trials
  • Mark Diaz, clinical professor, UC Davis School of Medicine, in support.
  • My name is Mark Diaz, clinical professor, UC Davis School of Medicine, in support. Thank you.
Keywords: 988, house, all
TX

Texas 89th Regular

Judiciary & Civil Jurisprudence May 21st, 2025

Judiciary & Civil Jurisprudence

Transcript Highlights:
  • As you know, this bill admitted certain evidence. into the trial, automatically there is now a notice
  • That report was conducted, I believe, by the UT Children's Law Clinic and was based, for the most part
  • Also, I've seen several cases where the appellate courts have sent cases back to the trial court and
  • So there's nothing preventing a person from waiting until the time of trial to request an attorney, which
  • delays the trial.
Bills: SB1960 , SB1730 , SB766 , SB2342 , SB2501 , SB2903
CA
Transcript Highlights:
  • to implement that bill; a one-time reversion of $38 million of the unrestricted fund balance in the Trial
  • So the first proposal relates to the $38 million one-time transfer of unrestricted monies from the Trial
  • accepts the $42 million restoration and $40 million ongoing for the trial courts.
  • accepts the $42 million restoration and $40 million ongoing for the trial courts.
  • We'd like to align our comments on trial courts along with SEIU.
Summary: The subcommittee heard May Revision presentations for the Office of Emergency Services, Judicial Branch, CDCR, and the Department of Justice, with the LAO offering comments and recommendations throughout. For Cal OES, the administration outlined funding for relocating the Red Mountain communications site, increased FEMA reimbursement authority, cybersecurity grants, next-generation 911 support, and a reduction to the Flexible Cash Assistance for Survivors of Crime program. Members raised concerns about VOCA backfill and disaster reimbursement, while the LAO recommended approving the 911 request with reporting, adding contingency planning for cybersecurity grants, clarifying the FEMA reimbursement language, and increasing reporting on emergency spending. For the Judicial Branch, the May Revision included funding for implementation of the Trial Nations Access to Justice Act, reductions tied to court facilities and employee benefits, and General Fund solutions such as a reduction to the pretrial release program, a reversion from the Trial Court Trust Fund, and elimination of the jury duty pilot program. The LAO cautioned that the pretrial reduction could affect detention and release decisions and recommended tighter legislative oversight over the trust fund transfer and reallocation language. Members questioned the impact of the pretrial cut, the lack of Prop. 36 court funding, and the rationale for the jury pilot elimination; the Judicial Branch said it was generally supportive of the budget as proposed. CDCR presented requests for roof repairs, fire alarm replacements, CalAIM-related costs, and trailer bill changes on incarcerated college students, mental health hiring, and tuberculosis testing, along with a planned prison closure by October 2026. The department also proposed reducing or delaying several items, including radio replacement, ADA improvements, COVID mitigation, and some facility upgrades, while adding a $125 million placeholder for consultant-driven operational savings. The LAO recommended rejecting or reducing several San Quentin-related proposals, questioned the staffing and contract medical requests, and urged more transparency on the consultant savings plan; members expressed concern about the realism of the savings targets and the potential legal or operational risks from delaying ADA and radio projects. For DOJ, the May Revision proposed ongoing funding and 44 positions to defend against federal actions, IT and accounting system upgrades, implementation funding for AB 1877, and a special fund loan. The LAO supported the KLETS connection but asked for a contingency plan if the new DMV link is delayed, noted that AB 1877 would not be fully implemented without additional funding, and recommended limiting and reporting on the federal accountability workload. Members questioned the size and permanence of the DOJ request, the use of the earlier $25 million special session appropriation, and the pace of federal litigation; DOJ said the new request would support ongoing litigation, expert assistance, and coordination across multiple cases and states.
CA

California 2025-2026 Regular Session

Senate Floor Session Jun 15th, 2026

California Senate Floor Meeting

Transcript Highlights:
  • Medi-Cal beneficiaries from last year's budget, which was scheduled to take effect this year, such as clinic
  • Meanwhile, it delays but does not yet reject cuts to dental and community clinic services for UIS enrollees
  • our residents who really need it, whether it's around dental or home health care or our community clinics
  • that those cuts don't continue to further harm people in our communities, that further close the clinics
  • that those cuts don't continue to further harm people in our communities, that further close the clinics
Keywords: 987, senate, all
NH

New Hampshire 2026 Regular Session

Senate Session (06/04/2026)

New Hampshire Senate Floor Meeting

Transcript Highlights:
  • Clinical trials are not bureaucracy for bureaucracy's sake.
  • Clinical trials are not bureaucracy for bureaucracy's sake.
  • Clinical trials are not bureaucracy for bureaucracy's sake.
  • </c><00:52:52.720><c> trials</c><00:52:53.200><c> and</c> compassionate care, clinical trials and compassionate
  • care, clinical trials and expanded<00:52:54.079><c> access</c><00:52:54.480><c> pathways</c><00:52:54.880
Keywords: 1191, senate, all
CA

California 2025-2026 Regular Session

Senate Health Committee Apr 22nd, 2026

Health

Transcript Highlights:
  • I'm also a research fellow at the Massachusetts General Hospital and currently help lead a clinical trial
  • I'm also a research fellow at the Massachusetts General Hospital and currently help lead a clinical trial
  • As a biosimilar, Eucinic has been found to be as clinically effective as Stelara.
  • From a clinical perspective, these are not optional.
  • This bill helps turn clinical recommendations into real care. I urge you to support SB 1309.
Committee: Senate Health
Keywords: 987, senate, all
TX

Texas 89th Regular

Insurance Apr 9th, 2025

Insurance

Transcript Highlights:
  • I own an outpatient clinic in Burnet, Texas.
  • trials being performed in the state.
  • The other 12% are the clinics and the different entities, and those really...
  • Our clients have access to all the data down to the clinic.
  • CMS is not required to explain their decisions or share clinical reasoning.
Committee: House Insurance
LA

Louisiana 2026 Regular Session

House of Representatives Apr 1st, 2026

Louisiana House Floor Meeting

Transcript Highlights:
  • House Bill 1216, by Representatives Broussard and Egan, governing guidelines for certain clinical laboratory
  • House Bill 1223, by Representative Smith-McFarlane, creating the Louisiana Early Phase Clinical Trial
  • Children's Code, videotaped statements of protected persons, accessibility, limits, and production at trial
Bills: HR91 , HR92 , HR93 , HCR44 , HR84 , HR85 , HR86 , HR87 , HR88 , HR89 , HR90 , HCR42 , HCR43 , SCR21 , HB483 , HB484 , HB893 , HB1087 , HB1088 , HB1089 , HB1090 , HB1091 , HB1092 , HB1093 , HB1094 , HB1095 , HB1096 , HB1097 , HB1098 , HB1099 , HB1100 , HB1101 , HB1102 , HB1103 , HB1104 , HB1105 , HB1106 , HB1107 , HB1108 , HB1109 , HB1110 , HB1111 , HB1112 , HB1113 , HB1114 , HB1116 , HB1117 , HB1118 , HB1119 , HB1120 , HB1121 , HB1122 , HB1123 , HB1124 , HB1125 , HB1126 , HB1127 , HB1128 , HB1129 , HB1130 , HB1131 , HB1132 , HB1133 , HB1134 , HB1135 , HB1136 , HB1137 , HB1138 , HB1139 , HB1140 , HB1141 , HB1142 , HB1143 , HB1144 , HB1145 , HB1146 , HB1147 , HB1148 , HB1149 , HB1150 , HB1151 , HB1152 , HB1153 , HB1154 , HB1155 , HB1156 , HB1157 , HB1158 , HB1159 , HB1160 , HB1161 , HB1162 , HB1163 , HB1164 , HB1165 , HB1166 , HB1167 , HB1168 , HB1169 , HB1170 , HB1171 , HB1172 , HB1173 , HB1174 , HB1175 , HB1176 , HB1177 , HB1178 , HB1179 , HB1180 , HB1181 , HB1182 , HB1183 , HB1184 , HB1185 , HB1186 , HB1187 , HB1188 , HB1189 , HB1190 , HB1191 , HB1192 , HB1193 , HB1194 , HB1195 , HB1196 , HB1197 , HB1198 , HB1199 , HB1200 , HB1201 , HB1202 , HB1203 , HB1204 , HB1205 , HB1206 , HB1207 , HB1208 , HB1209 , HB1210 , HB1211 , HB1212 , HB1213 , HB1214 , HB1215 , HB1216 , HB1217 , HB1218 , HB1219 , HB1220 , HB1221 , HB1222 , HB1223 , HB1224 , HB1225 , HB1226 , HB1227 , HB1228 , HB1229 , HB1230 , HB1231 , SB1 , SB54 , SB82 , SB87 , SB92 , SB93 , SB99 , SB104 , SB113 , SB114 , SB115 , SB123 , SB129 , SB133 , SB161 , SB162 , SB224 , SB236 , SB275 , SB280 , SB289 , SB305 , SB310 , SB325 , SB330 , SB339 , SB350 , SB359 , SB382 , SB410 , SB412 , HCR10 , HB54 , HB55 , HB67 , HB73 , HB125 , HB133 , HB158 , HB168 , HB169 , HB191 , HB195 , HB205 , HB225 , HB245 , HB280 , HB283 , HB296 , HB319 , HB325 , HB339 , HB399 , HB407 , HB448 , HB482 , HB550 , HB591 , HB821 , HB826 , HB992 , HB995 , HB1085 , HB1086 , HR15 , HR20 , HCR14 , HCR6 , HCR19 , HB861 , HB889 , HB904 , HB907 , HB908 , HB929 , HB1009 , HB13 , HB23 , HB25 , HB32 , HB41 , HB90 , HB120 , HB121 , HB122 , HB127 , HB138 , HB139 , HB141 , HB179 , HB187 , HB213 , HB247 , HB286 , HB332 , HB344 , HB357 , HB367 , HB370 , HB462 , HB505 , HB527 , HB537 , HB605 , HB680 , HB681 , HB725 , HB780 , HB782 , HB847 , HB892 , HB911 , HB916 , HB1012 , HB81 , HB134 , HB154 , HB163 , HB170 , HB194 , HB217 , HB220 , HB254 , HB259 , HB290 , HB308 , HB311 , HB360 , HB382 , HB401 , HB410 , HB417 , HB463 , HB575 , HB592 , HB718 , HB723 , HB750 , HB755 , HB776 , HB812 , HB844 , HB882 , HB888 , HB961 , HB966 , HB980 , HB228 , HB289 , HB735 , HB796 , HB284 , HB301 , HB722 , HB468 , HB546 , HB746 , HB842 , HB923 , HB46 , HB166 , HB349 , HB352 , HB436 , HB588 , HB140 , HB429 , HB827 , HB953 , HB901 , HB9 , HB52 , HB58 , HB193 , HB400 , HB570 , HB577 , HB582 , HB733 , HB747 , HB868 , HB952
MO

Missouri 2026 Regular Session

Professional Registration and Licensing Mar 4th, 2026 at 08:00 am

Professional Registration and Licensing

Transcript Highlights:
  • the provision that you all have heard and passed out 20 to 0 that fixes the issue of doing your clinical
  • for regulatory refinement through the Board of Optometry, and House Bill 2999 instead micromanages clinical
  • But when you take the RRT, it’s the multiple-choice in addition to the clinical setting trials.
  • I don’t think it’s all that much harder if we’re just talking about a clinical setting test or trial.
  • Whereas the RRT, they're required to go and take what's called a clinical simulation exam, where they
Keywords: 959, house, all
TX

Texas 89th Regular

Human Services Mar 4th, 2025

Human Services

Transcript Highlights:
  • You've got the licensed. master's level social worker, and then the licensed clinical social worker.
  • The LCSWs, or the clinical social workers, are the ones that are licensed. folks.
  • And that's a situation where a provider can add a code to a clinic. name in order to get it paid.
  • , it's a mini-trial.
  • Of course, we try to resolve them. without ever going to trial.
Keywords: 1184, house, all
US
Transcript Highlights:
  • That trial is happening right now in Los Angeles.
  • Those questions will be answered by a jury in that trial.
  • Are you aware of the Clinical Immunization Safety Assessment Project?
  • Numerous clinical trials, rigorous studies, and review by an independent panel of experts show that vaccines
  • trials for years, and I could go on.
HI

Hawaii 2026 Regular Session

JHA Public Hearing - Thu Feb 19, 2026 @ 2:00 PM HST

Judiciary & Hawaiian Affairs

Transcript Highlights:
  • </c> on average being held pre-trial on average being held pre-trial misdemeanor<01:18:56.640><c> in<
  • </c> of pre-trial decisions. First up, Mr. of pre-trial decisions. First up, Mr.
  • </c> discretion to detain pre-trial discretion to detain pre-trial defendants,<01:40:19.920><c> it</c
  • That's what that study showed. jail before a trial than the length of jail before a trial than the length
  • ><c> before</c><02:04:03.360><c> any</c> Um, but pre-trial happens before any Um, but pre-trial happens
Keywords: 910, house, all
Summary: The House Committee on Judiciary and Hawaiian Affairs recessed briefly for a joint hearing, then reconvened and took up House Bill 2494, which would limit warrantless arrests for petty misdemeanors and violations, require officers to document arrest justification, expand citation-in-lieu-of-arrest use, and direct the Judiciary to create a standardized citation form. The chair also outlined hearing procedures and testimony time limits. Committee members later received an overview from the Policing Project about national trends in expanding citation use. Testimony was divided. Supporters, including the Office of Hawaiian Affairs, the Hawaii Correctional System Oversight Commission, the Office of the Public Defender, the ACLU of Hawaii, the Drug Policy Forum of Hawaii, and the Policing Project, argued the bill would reduce unnecessary arrests and pretrial detention, lessen jail overcrowding, save law enforcement time, and reduce harms such as job loss, housing instability, family disruption, and recidivism. They also said the bill preserves officer discretion through public-safety and flight-risk exceptions, and several supporters urged the committee to adopt a standardized citation form despite the Judiciary’s request for a delayed implementation date. Opposition came from the Department of the Attorney General, the Judiciary, county prosecutors, Honolulu Police Department, and other individuals. They argued the bill would unduly restrict law enforcement discretion, create administrative and data-processing problems, and make it harder to identify repeat or habitual offenders because of changes to citation information and fingerprinting. The Judiciary requested implementation no earlier than January 1, 2028 and said the citation form would need major changes. Opponents also warned the bill could increase litigation, suppress evidence, and not meaningfully reduce overcrowding because most jail populations are held on felony matters. The chair reported 14 testimonies in support, 21 in opposition, and one with comments; no vote or final action was taken in the portion provided.